000			01750 a2200457 4500
005			20250516155951.0
264		0	_c20140327
008			201403s 0 0 eng d
022			_a1759-507X
024	7		_a10.1038/nrneph.2013.125 _2doi
040			_aNLM _beng _cNLM
100	1		_aHofstra, Julia M
245	0	0	_aTreatment of idiopathic membranous nephropathy. _h[electronic resource]
260			_bNature reviews. Nephrology _cAug 2013
300			_a443-58 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAdrenocorticotropic Hormone _xtherapeutic use
650	0	4	_aAlgorithms
650	0	4	_aAlkylating Agents _xtherapeutic use
650	0	4	_aAntibodies _xanalysis
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aAntimetabolites _xtherapeutic use
650	0	4	_aCalcineurin Inhibitors
650	0	4	_aGlomerulonephritis, Membranous _xdiagnosis
650	0	4	_aGlucocorticoids _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use
650	0	4	_aImmunologic Factors _xtherapeutic use
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aPrognosis
650	0	4	_aProteinuria _xprevention & control
650	0	4	_aReceptors, Phospholipase A2 _ximmunology
650	0	4	_aRenin-Angiotensin System
650	0	4	_aRituximab
700	1		_aFervenza, Fernando C
700	1		_aWetzels, Jack F M
773	0		_tNature reviews. Nephrology _gvol. 9 _gno. 8 _gp. 443-58
856	4	0	_uhttps://doi.org/10.1038/nrneph.2013.125 _zAvailable from publisher's website
999			_c22886009 _d22886009